Dezhan Healthcare Company Limited
000813.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.84B
Close$
$0.11
96.8% downside
Current Fair Value
96.8% downsideOvervalued by 96.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.84 Billion |
|---|---|
| Enterprise Value | $5.62 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.16 |
| Beta | 0.44 |
| Outstanding Shares | 2,097,105,540 |
Return
| Return on Equity | -7.88% |
|---|---|
| Return on Assets | -7.56% |
| Return on Invested Capital | -4.04% |
Valuation & Multiples
| P/E Ratio | -19.61 |
|---|---|
| PEG | -137.73 |
| Price to Sales | - |
| Price to Book Ratio | 1.67 |
| Enterprise Value to Revenue | 15.08 |
| Enterprise Value to EBIT | -30.01 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Dezhan Healthcare Company Limited
1,195 employees
CEO: Wei Liu Dezhan Healthcare Company Limited operates primarily within the Chinese market, specializing in the research, development, manufacturing, and distribution of pharmaceutical products, with a particular focus on cardiovascular and cerebrov...